Sangamo Shares Plunge as Pfizer Exits Partnership
Sangamo Therapeutics' stock plummeted by over 50% following Pfizer's decision to withdraw from their joint agreement. Explore the impact on biotech stocks.
Sangamo Therapeutics shares decreased over 50% after Pfizer exited their collaborative agreement.